Measuring and Control Equipment Companies By Current Ratio

Current Ratio
Current RatioEfficiencyMarket RiskExp Return
1NAUT Nautilus Biotechnology
49.75
 0.03 
 4.77 
 0.16 
2QSI QuantumSi
35.44
 0.08 
 6.66 
 0.54 
3FCUV Focus Universal
23.35
(0.19)
 8.92 
(1.69)
4OMIC Singular Genomics Systems
22.98
(0.08)
 5.00 
(0.42)
5MASS 908 Devices
15.46
(0.07)
 3.65 
(0.27)
6ELSE Electro Sensors
11.68
 0.01 
 1.95 
 0.01 
7QTRX Quanterix Corp
11.27
(0.13)
 3.44 
(0.44)
8PACB Pacific Biosciences of
11.19
(0.19)
 8.11 
(1.52)
9EYPT Eyepoint Pharmaceuticals
6.16
(0.11)
 3.98 
(0.45)
10ONTO Onto Innovation
6.14
 0.11 
 3.08 
 0.33 
11OPXS Optex Systems Holdings
5.97
 0.10 
 3.22 
 0.33 
12LAB Standard Biotools
5.87
 0.03 
 2.86 
 0.10 
13TXG 10X Genomics
5.65
(0.22)
 2.93 
(0.66)
14BIO Bio Rad Laboratories
5.5
(0.10)
 1.92 
(0.18)
15OLK Olink Holding AB
5.33
(0.06)
 1.47 
(0.09)
16PRE Prenetics Global
5.05
 0.06 
 7.13 
 0.42 
17NVMI Nova
4.98
 0.12 
 2.60 
 0.32 
18GEOS Geospace Technologies
4.62
(0.06)
 3.52 
(0.22)
19HURC Hurco Companies
3.58
(0.12)
 3.44 
(0.42)
20BMI Badger Meter
3.2
 0.21 
 2.41 
 0.50 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company. Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).